Svitlana Tyekucheva

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.518Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

Papers

Driven by 21 papers — median percentile 63. Top paper: “Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study”.

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00455-1

N/A

3.3DataRank · unranked

104 citations

Benjamin L. Lampson, Svitlana Tyekucheva, Zixu Wang, Jessica Lowney, Samantha Pazienza +13 more

Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations

Cancer Research(2009)10.1158/0008-5472.can-09-1133

N/A

0.927DataRank · unranked

481 citations

Sining Chen, Leyla Isik, Svitlana Tyekucheva, Victor E. Velculescu, Kenneth W. Kinzler +4 more

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

SAVE (Safe Accelerated Venetoclax Escalation): Initial results of a prospective, phase Ib study of venetoclax with an accelerated dose ramp-up in patients with CLL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7512

N/A

0.165DataRank · unranked

2 citations

Inhye E. Ahn, Svitlana Tyekucheva, Reid W. Merryman, David C. Fisher, Philippe Armand +7 more

Transcriptional landscape of PTEN loss in primary prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.08.332049

N/A

0DataRank · unranked

2 citations

Diego F. Sánchez, Wikum Dinalankara, Thiago Vidotto, Ericka M. Ebot, Svitlana Tyekucheva +7 more

Transcriptional landscape of PTEN loss in primary prostate cancer

BMC Cancer(2021)10.1186/s12885-021-08593-y

N/A

0DataRank · unranked

34 citations

Diego F. Sánchez, Wikum Dinalankara, Thiago Vidotto, Ericka M. Ebot, Svitlana Tyekucheva +7 more

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01441-9

N/A

0DataRank · unranked

21 citations

Alec Griffith, Svitlana Tyekucheva, Zixu Wang, Vanessa Rai, Alexander R. Vartanov +14 more

Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1461

N/A

0DataRank · unranked

4 citations

Giovanni Parmigiani, Edward L. Giovannucci, Eric B. Rimm, Svitlana Tyekucheva, Massimo Loda +6 more

Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.29.450369

N/A

0DataRank · unranked

3 citations

Svitlana Tyekucheva, Molin Wang, Travis Gerke, Jane B. Vaselkiv, Kathryn L. Penney +8 more

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Blood Advances(2022)10.1182/bloodadvances.2022008447

N/A

0DataRank · unranked

80 citations

Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stephen P. Martindale +20 more

Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia

British Journal of Haematology(2022)10.1111/bjh.18053

N/A

0DataRank · unranked

15 citations

Alec Griffith, Zixu Wang, Svitlana Tyekucheva, Vanessa Rai, Stacey M. Fernandes +5 more

The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0627

N/A

0DataRank · unranked

10 citations

Yinglu Zhou, Giuseppe Nicolò Fanelli, Konrad H. Stopsack, Michelangelo Fiorentino, Giorgia Zadra +5 more

Cross-Study Replicability in Cluster Analysis

Statistical Science(2023)10.1214/22-sts871

N/A

0DataRank · unranked

4 citations

Emma G. Thomas, Giovanni Parmigiani, Svitlana Tyekucheva, Lorenzo Trippa, Lorenzo Masoero

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

Blood Cancer Journal(2023)10.1038/s41408-023-00788-9

N/A

0DataRank · unranked

3 citations

Stephen P. Martindale, Pui Yan Chiu, Jasneet Kaur Khalsa, Pei-Hsuan Chen, Stacey M. Fernandes +10 more

Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

(2023)10.1158/1541-7786.c.6545205.v1

N/A

0DataRank · unranked

0 citations

Svitlana Tyekucheva, Jacob Rosenthal, Habiba El Fandy, Ryan Carelli, Stephanie Borgstein +13 more

Investigating the influence of germline ATM variants in chronic lymphocytic leukemia on cancer vulnerability

Haematologica(2024)10.3324/haematol.2024.286031

N/A

0DataRank · unranked

3 citations

Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey M. Fernandes +7 more

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006

N/A

0DataRank · unranked

12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

HemaSphere(2025)10.1002/hem3.70067

N/A

0DataRank · unranked

0 citations

Yue Ren, Svitlana Tyekucheva, Jon Arnason, Adam Boruchov, Caron A. Jacobson +6 more

Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell–Level PI3K Pathway Activation

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2000

N/A

0DataRank · unranked

13 citations

Ying Huang, Svitlana Tyekucheva, Travis Gerke, Clyde Bango, Habiba Elfandy +8 more

Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0548

N/A

0DataRank · unranked

45 citations

Svitlana Tyekucheva, Jacob Rosenthal, Habiba El Fandy, Ryan Carelli, Stephanie Borgstein +13 more

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

American Journal of Hematology(2020)10.1002/ajh.26084

N/A

0DataRank · unranked

29 citations

Sarah R. Walker, Lisa N. Heppler, Svitlana Tyekucheva, Erik A. Nelson, Josephine L. Klitgaard +15 more

Svitlana Tyekucheva

Indexed papers

Top data-sharing exemplar

Papers